Article and Video CATEGORIES

Cancer Journey

Search By

Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and the Veteran’s Administration Medical Center

ASCO/ESMO 2020 PembroRAD Trial Update
Outcome of the PembroRAD Trial: Pembrolizumab (Keytruda) or Cetuximab (Erbitux) Combined with Radiation Therapy in Patients with Locally Advanced HNSCC
Author
Joshua Bauml, MD, Advisory Board Member, GRACE Faculty
Image
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates to head and neck cancer treatments and trials.

Dr. Joshua Bauml, Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and Dr. Jared Weiss, Associate Professor of Medicine at UNC Chapel Hill and Vice President of the Board of GRACE chaired this program highlighting updates for those dealing with a diagnosis of locally advanced HNSCC. Drs. Bauml and Weiss spoke with Dr. Kathryn Gold, Medical Oncologist and Associate Professor of Medicine at the University of California San Diego and Dr. Ranee Mehra, Professor of Medical Oncology at the University of Maryland, on the newest updates to 2020 trials and studies presented at ASCO and ESMO this year.

For this discussion, Drs. Bauml, Weiss, Gold and Mehra discuss the outcome of the PembroRAD Trial: Pembrolizumab (Keytruda) or Cetuximab (Erbitux) combined with radiation therapy in patients with locally advanced HNSCC.

 

To join the conversation, visit https://cancergrace.org/forum.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

Recent Comments

JOIN THE CONVERSATION
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on
Amivantamab and Lazertinib
By happybluesun on
Glad to help.  FYI, I just…
By JanineT GRACE … on